Acupuncture for postprandial distress syndrome (APDS): study protocol for a randomized controlled trial

被引:6
作者
Yang, Jing-Wen [1 ]
Zhang, Li-Wen [1 ]
Shi, Guang-Xia [1 ]
Du, Yi [2 ]
Wang, Jun [3 ]
Zhao, Jing-Jie [2 ]
Cao, Yan [1 ]
Tu, Jian-Feng [1 ]
Zhang, Shuai [1 ]
Tan, Cheng [3 ]
Chen, San-San [3 ]
Liu, Cun-Zhi [1 ]
机构
[1] Capital Med Univ, Beijing Key Lab Acupuncture Neuromodulat, Beijing Hosp Tradit Chinese Med, Dept Acupuncture & Moxibust, 23 Meishuguanhou St, Beijing 100010, Peoples R China
[2] Capital Med Univ, Beijing Friendship Hosp, Dept Tradit Chinese Med, Beijing, Peoples R China
[3] Beijing Univ Tradit Chinese Med, Dongzhimen Hosp, Acupuncture & Moxibust Dept, Beijing, Peoples R China
来源
TRIALS | 2017年 / 18卷
关键词
Postprandial distress syndrome; Functional dyspepsia; Acupuncture; Randomized controlled trial; Minimal acupuncture; QUALITY-OF-LIFE; FUNCTIONAL GASTROINTESTINAL DISORDERS; PLACEBO-CONTROLLED TRIAL; PRIMARY-CARE PATIENTS; UNINVESTIGATED DYSPEPSIA; METAANALYSIS; SYMPTOMS; IMPACT; POPULATION; PREVALENCE;
D O I
10.1186/s13063-017-2285-9
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Postprandial distress syndrome (PDS) is referred to as meal-related functional dyspepsia (FD) and causes a reduced quality of life (QoL) for patients. Several randomized controlled trials (RCTs) have suggested that acupuncture is an effective treatment for FD, but few studies were particularly for PDS. This pilot study was designed to determine the feasibility and efficacy of acupuncture in patients with PDS characterized by postprandial fullness and early satiation according to the Rome III criteria. Methods: This is a multi-center, two-arm, blinded (participants), pilot RCT. Forty-two participants who meet the inclusion criteria will be randomly assigned to the verum acupuncture group or minimal acupuncture group in a 1: 1 ratio. Both treatments consist of 12 sessions of 20 min duration over four weeks (three sessions per week). The primary outcome measurement is the proportion of persons who improve as assessed using the global outcome by the overall treatment effect (OTE) at end-of-treatment (EOT) (four weeks after randomization). Global assessment at weeks 8 and 16 after randomization is one of the secondary outcomes. The other secondary outcomes including symptoms, disease-specific QoL, and depression and anxiety will be assessed at weeks 4, 8, and 16 after randomization. Discussion: This pilot study will help determine the feasibility and efficacy of acupuncture in patients with PDS.
引用
收藏
页数:8
相关论文
共 34 条
  • [1] Review article: endpoints used in functional dyspepsia drug therapy trials
    Ang, D.
    Talley, N. J.
    Simren, M.
    Janssen, P.
    Boeckxstaens, G.
    Tack, J.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 33 (06) : 634 - 649
  • [2] Heartburn-dominant, uninvestigated dyspepsia:: a comparison of 'PPI-start' and 'H2-RA-start' management strategies in primary care -: the CADET-HR Study
    Armstrong, D
    van Zanten, SJOV
    Barkun, AN
    Chiba, N
    Thomson, ABR
    Smyth, S
    Sinclair, P
    Chakraborty, B
    White, RJ
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 21 (10) : 1189 - 1202
  • [3] Functional dyspepsia impairs quality of life in the adult population
    Aro, P.
    Talley, N. J.
    Agreus, L.
    Johansson, S. -E.
    Bolling-Sternevald, E.
    Storskrubb, T.
    Ronkainen, J.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 33 (11) : 1215 - 1224
  • [4] CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomized Trials
    Bian, Zhao-xiang
    Shang, Hong-cai
    [J]. ANNALS OF INTERNAL MEDICINE, 2011, 154 (04) : 290 - 291
  • [5] Functional Dyspepsia Impacts Absenteeism and Direct and Indirect Costs
    Brook, Richard A.
    Kleinman, Nathan L.
    Choung, Rok Seon
    Melkonian, Arthur K.
    Smeeding, James E.
    Talley, Nicholas J.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2010, 8 (06) : 498 - 503
  • [6] Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: Results of the US upper gastrointestinal study
    Camilleri, M
    Dubois, D
    Coulie, B
    Jones, M
    Kahrilas, PJ
    Rentz, AM
    Sonnenberg, A
    Stanghellini, V
    Stewart, WF
    Tack, J
    Talley, NJ
    Whitehead, W
    Revicki, DA
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2005, 3 (06) : 543 - 552
  • [7] Impact of Functional Gastrointestinal Disorders on Survival in the Community
    Chang, Joseph Y.
    Locke, G. Richard, III
    McNally, Meredythe A.
    Halder, Smita L.
    Schleck, Cathy D.
    Zinsmeister, Alan R.
    Talley, Nicholas J.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 (04) : 822 - 832
  • [8] Treating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia:: the Canadian adult dyspepsia empiric treatment -: Helicobacter pylori positive (CADET-Hp) randomised controlled trial
    Chiba, N
    van Zanten, SJOV
    Sinclair, P
    Ferguson, RA
    Escobedo, S
    Grace, E
    [J]. BRITISH MEDICAL JOURNAL, 2002, 324 (7344): : 1012 - +
  • [9] Who consults with dyspepsia? Results from a longitudinal 10-yr follow-up study
    Ford, Alexander C.
    Forman, David
    Bailey, Alastair G.
    Cook, Michael B.
    Axon, Anthony T. R.
    Moayyedi, Paul
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 (05) : 957 - 965
  • [10] Global prevalence of, and risk factors for, uninvestigated dyspepsia: a meta-analysis
    Ford, Alexander C.
    Marwaha, Avantika
    Sood, Ruchit
    Moayyedi, Paul
    [J]. GUT, 2015, 64 (07) : 1049 - 1057